Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

被引：0
|
作者：
Wenzl, F. [1 ]
Kraler, S. [1 ]
Raeber, L. [2 ]
Von Eckardstein, A. [3 ]
Matter, C. [4 ]
Gencer, B. [5 ]
Nanchen, D. [6 ]
Rodondi, N. [7 ]
Mach, F. [5 ]
Luescher, T. [8 ]
机构：
[1] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[2] Inselspital Bern, Bern Univ Hosp, Dept Cardiol, Bern, Switzerland
[3] Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland
[4] Univ Hosp Zurich, Dept Cardiol, Zurich, Switzerland
[5] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland
[6] Univ Lausanne, Ctr Primary Care & Publ Hlth, Lausanne, Switzerland
[7] Inselspital Bern, Bern Univ Hosp, Dept Gen Internal Med, Bern, Switzerland
[8] Imperial Coll London, Royal Brampton Hosp, London, England
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1169 / 1169
页数：1
相关论文
共 50 条
  • [1] REMNANT CHOLESTEROL AND RESIDUAL RISK AFTER ACUTE CORONARY SYNDROME
    Schwartz, Gregory G.
    Abt, Markus
    Miller, Michael
    Mundl, Hardi
    Olsson, Anders
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A257 - A257
  • [2] Remnant cholesterol in patients admitted for acute coronary syndromes
    Cordero, Alberto
    Alvarez-Alvarez, Belen
    Escribano, David
    Garcia-Acuna, Jose Ma
    Cid-Alvarez, Belen
    Rodriguez-Manero, Moises
    Amparo Quintanilla, M.
    Agra-Bermejo, Rosa
    Zuazola, Pilar
    Gonzalez-Juanatey, Jose R.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (04) : 340 - 348
  • [3] Lipid levels after acute coronary syndromes
    Pitt, Bertram
    Loscalzo, Joseph
    Ycas, Joseph
    Raichlen, Joel S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) : 1440 - 1445
  • [4] The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention
    Liao, Jia
    Qiu, Miaohan
    Su, Xiaolin
    Qi, Zizhao
    Xu, Ying
    Liu, Haiwei
    Xu, Kai
    Wang, Xiaozeng
    Li, Jing
    Li, Yi
    Han, Yaling
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [5] Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes
    Meeusen, Jeffrey W.
    Donato, Leslie J.
    Jaffe, Allan S.
    [J]. CURRENT CARDIOLOGY REPORTS, 2017, 19 (06)
  • [6] Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes
    Jeffrey W. Meeusen
    Leslie J. Donato
    Allan S. Jaffe
    [J]. Current Cardiology Reports, 2017, 19
  • [7] High-density Lipoproteins After Acute Coronary Syndromes: Evaluation of Residual Risk
    Facila, Lorenzo
    Nunez, Julio
    Sanchis, Juan
    Cordero, Alberto
    Fabregat-Andres, Oscar
    Morell, Salvador
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2013, 66 (01): : 65 - 66
  • [8] Residual inflammatory risk at 12 months after acute coronary syndromes is associated with cardiovascular outcome
    Klingenberg, R.
    Aghlmandi, S.
    Nanchen, D.
    Raeber, L.
    Gencer, B.
    Carballo, D.
    Carballo, S.
    Landmesser, U.
    Rodondi, N.
    Mach, F.
    Windecker, S.
    Bucher, H. C.
    Von Eckardstein, A.
    Luescher, T. F.
    Matter, C. M.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 1687 - 1687
  • [9] Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry
    Cordero, Alberto
    Fernandez Olmo, M. Rosa
    Cortez Quiroga, Gustavo A.
    Romero-Menor, Cesar
    Facila, Lorenzo
    Seijas-Amigo, Jose
    Rondan Murillo, Juan
    Sandin, Miriam
    Rodriguez-Manero, Moises
    Bello Mora, Maria C.
    Valle, Alfonso
    Fornovi, Aisa
    Freixa Pamias, Roman
    Baneras, Jordi
    Blanch Garcia, Pedro
    Clemente Lorenzo, Maria Milagros
    Sanchez-Alvarez, Sergio
    Lopez-Rodriguez, Luis
    Gonzalez-Juanatey, Jose R.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (12)
  • [10] Risk factor management after acute coronary syndromes
    Melloni, Chiara
    Newby, L. Kristin
    [J]. HEART, 2009, 95 (17) : 1382 - 1384
12345